Literature DB >> 10402510

Lithium responsive bipolar disorder, unilineality, and chromosome 18: A linkage study.

G Turecki1, P Grof, P Cavazzoni, A Duffy, E Grof, R Martin, R Joober, G A Rouleau, M Alda.   

Abstract

Over the last three years several studies have investigated the hypothesis of linkage between bipolar disorder and markers on chromosome 18. Although independent groups have reported positive results, it is still not clear how these should be interpreted, as linkage spans a considerably large segment of the chromosome. In this study we have investigated linkage with chromosome 18 markers in 19 families of lithium-responsive bipolar patients, as a way to select a more homogeneous population. In addition, we have investigated whether there is evidence of a parent-of-origin effect as suggested by previous studies. Eleven markers spanning the whole chromosome were typed and linkage analysis was carried out using parametric and nonparametric methods. Analysis of the whole sample provided nonsignificant linkage results. However, when the sample included only unilineal families, and was further stratified according to parental origin, two chromosomal regions provided modestly positive lod scores. Maximum lod scores of 1.04 (P = 0.001) at D18S53 and 0.87 (P = 0.045) at D18S61 were observed for maternal and paternal pedigrees, respectively. Nonparametric analysis yielded similar results. In conclusion, our results are congruent with previous reports that suggest an advantage of unilineal pedigrees in linkage analysis of bipolar disorder and cannot rule out a parent-of-origin effect in this genomic region. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10402510     DOI: 10.1002/(sici)1096-8628(19990820)88:4<411::aid-ajmg20>3.0.co;2-9

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  11 in total

Review 1.  Review of bipolar molecular linkage and association studies.

Authors:  Wade Berrettini
Journal:  Curr Psychiatry Rep       Date:  2002-04       Impact factor: 5.285

Review 2.  Bipolar disorder and schizophrenia: convergent molecular data.

Authors:  Wade Berrettini
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

3.  Genetics of major mood disorders.

Authors:  Wade Berrettini
Journal:  Psychiatry (Edgmont)       Date:  2004-09

4.  Bipolar disorder and schizophrenia: not so distant relatives?

Authors:  Wade Berrettini
Journal:  World Psychiatry       Date:  2003-06       Impact factor: 49.548

Review 5.  The common genetic liability between schizophrenia and bipolar disorder: a review.

Authors:  E Bramon; P C Sham
Journal:  Curr Psychiatry Rep       Date:  2001-08       Impact factor: 5.285

Review 6.  Response to treatment in bipolar disorder.

Authors:  Cristiana Cruceanu; Martin Alda; Guy Rouleau; Gustavo Turecki
Journal:  Curr Opin Psychiatry       Date:  2011-01       Impact factor: 4.741

7.  Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder.

Authors:  Alessio Squassina; Mirko Manchia; Maria Del Zompo
Journal:  Hum Genomics Proteomics       Date:  2010-08-03

Review 8.  Long-term responsiveness to lithium as a pharmacogenetic outcome variable: treatment and etiologic implications.

Authors:  Firoza Mamdani; Iris Jaitovich Groisman; Martin Alda; Gustavo Turecki
Journal:  Curr Psychiatry Rep       Date:  2003-12       Impact factor: 5.285

Review 9.  Molecular actions and clinical pharmacogenetics of lithium therapy.

Authors:  Adem Can; Thomas G Schulze; Todd D Gould
Journal:  Pharmacol Biochem Behav       Date:  2014-02-15       Impact factor: 3.533

10.  A gene co-expression module implicating the mitochondrial electron transport chain is associated with long-term response to lithium treatment in bipolar affective disorder.

Authors:  David Stacey; K Oliver Schubert; Scott R Clark; Azmeraw T Amare; Elena Milanesi; Carlo Maj; Susan G Leckband; Tatyana Shekhtman; John R Kelsoe; David Gurwitz; Bernhard T Baune
Journal:  Transl Psychiatry       Date:  2018-09-05       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.